Skip to main content

Table 2 Patient characteristics

From: Dosimetric advantage of volumetric modulated arc therapy in the treatment of intraocular cancer

Patient

Sex

Age

Diagnosis

Location

PTV volume (cm3)

1

Male

47

Malt lymphoma

Left eye

20.88

2

Male

43

Orbital adenocarcinoma

Left eye

48.50

3

Male

55

Malt lymphoma

Left eye

31.85

4

Male

47

Orbital tumor

Right eye

38.45

5

Male

49

Orbital tumor

Right eye

11.65

6

Female

80

Eyelid carcinoma

Left eye

28.89

7

Male

56

Malt lymphoma

Right eye

22.89

8

Female

59

Lung metastasis

Left eye

83.74

9

Male

65

Malt lymphoma

Right eye

46.11

10

Female

41

Malt lymphoma

Left eye

10.11

11

Male

59

Malt lymphoma

Right eye

14.97

12

Male

56

Malt lymphoma

Left eye

20.84

13

Female

33

Orbital adenocarcinoma

Left eye

8.87

14

Female

78

Malt lymphoma

Right eye

27.34